Novartis AG - Total Cashflows From Investing Activities

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Cashflows-From-Investing-Activities" stands at -5.81 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Novartis AG's third quarter result of -0.86 Billion USD for the item "Total Cashflows From Investing Activities" represents an increase of 61.66 percent compared to it's second quarter result.

Also, Novartis AG's third quarter result of -0.86 Billion USD for the item "Total Cashflows From Investing Activities" represents a decrease of -129.95 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's third quarter result of -5.81 Billion USD for the item "Total Cashflows From Investing Activities" represents a decrease of -9.14 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.1058 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.1058 Billion United States Dollars.
The 3 year change is -13.30 Billion United States Dollars.
The 5 year change is 6.49 Billion United States Dollars.
The 10 year change is 4.21 Billion United States Dollars.

The Serie's long term average value is -3.22 Billion United States Dollars. It's latest available value, on 09/30/2025, is -2.59 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2020, to it's latest available value, on 09/30/2025, is +7.89 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -19.10 Billion.